Rosuvastatin calcium and process for producing intermediate thereof
US-2024360086-A1 · Oct 31, 2024 · US
US11060099B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11060099-B2 |
| Application number | US-201715650285-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 14, 2017 |
| Priority date | Apr 2, 2012 |
| Publication date | Jul 13, 2021 |
| Grant date | Jul 13, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to compositions and methods, including polynucleotide sequences, amino acid sequences, recombinant host cells and recombinant host cell cultures engineered to produce fatty acid derivative compositions comprising fatty acids, fatty alcohols, fatty aldehydes, fatty esters, alkanes, terminal olefins, internal olefins or ketones. The fatty acid derivative composition is produced extracellularly with a higher titer, yield or productivity than the corresponding wild type or non-engineered host cell.
Opening claim text (preview).
We claim: 1. A recombinant host cell comprising a transposon insertion in a yijP gene, wherein the yijP gene is flanked by a gene encoding a phosphoenolpyruvate carboxylase (ppc) polypeptide, and wherein the transposon insertion down-regulates the ppc gene, and wherein the recombinant host cell further expresses an exogenous polynucleotide encoding a thioesterase, wherein said recombinant host cell produces a fatty acid derivative composition at a higher titer, yield or productivity than a corresponding wild type host cell when cultured in a medium containing a carbon source under conditions effective to express said ppc polypeptide. 2. A cell culture comprising the recombinant host cell according to claim 1 . 3. The cell culture of claim 2 , wherein the fatty acid derivative is a) a C6, C8, C10, C12, C13, C14, C15, C16, C17, or C18 fatty acid derivative, or b) a C10:1, C12:1, C14:1, C16:1, or C18:1 unsaturated fatty acid derivative. 4. The cell culture of claim 2 , wherein said recombinant host cell produces a fatty acid derivative yield that is at least about 5% greater than that of said corresponding wild type host cell when cultured under the same conditions as the recombinant host cell. 5. The cell culture of claim 4 , wherein said titer is from about 1 g/L to about 70 g/L. 6. The cell culture of claim 2 , wherein said recombinant host cell produces a fatty acid derivative yield that is at least about 10% to about 40% greater than that of said corresponding wild type host cell when cultured under the same conditions as the recombinant host cell. 7. The cell culture of claim 2 , wherein said productivity ranges from about 0.7 mg/L/hr to about 3 g/L/hr. 8. The cell culture of claim 2 , wherein said cell culture comprises a fatty acid derivative composition. 9. The cell culture of claim 8 , wherein the fatty acid derivative composition comprises at least one fatty acid derivative selected from the group consisting of fatty acid, a fatty ester, a fatty alcohol, a fatty aldehyde, an alkane, a terminal olefin, an internal olefin, and a ketone. 10. The cell culture of claim 8 , wherein the fatty acid derivative composition comprises: a) one or more of C8, C10, C12, C14, C16, and C18 fatty acid derivatives, b) fatty acids, c) fatty aldehydes, d) fatty alcohols, e) fatty esters, f) alkanes, g) terminal olefins, h) internal olefins, or i) ketones. 11. The cell culture of claim 8 , wherein the fatty acid derivative composition comprises fatty acid derivatives having a double bond at position 7 in the carbon chain between C7 and C8 from the reduced end of a fatty alcohol. 12. The cell culture of claim 8 , wherein the fatty acid derivative composition comprises unsaturated fatty acid derivatives. 13. The cell culture of claim 8 , wherein the fatty acid derivative composition comprises saturated fatty acid derivatives. 14. The cell culture of claim 8 , wherein the fatty acid derivative composition comprises branched chain fatty acid derivatives.
acting on CH-OH groups as donors (1.1) · CPC title
Fatty acids · CPC title
Transferases for other substituted phosphate groups (2.7.8) · CPC title
Holo-[acyl-carrier-protein] synthase (2.7.8.7) · CPC title
Enoyl-[acyl-carrier-protein] reductase (NADH) (1.3.1.9) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.